Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aspirin Ad Claims For Cardiovascular Benefits Allowed In UK Proposal

This article was originally published in The Tan Sheet

Executive Summary

Promoting aspirin 75 mg to consumers for secondary prevention of heart attack or stroke would be permitted in the UK under a proposal issued for consultation by the country's Medicines Control Agency Nov. 4

You may also be interested in...



UK on OTC ads

Guidelines for advertisements promoting OTCs for previously restricted indications are expected by year-end, UK's Medicines & Healthcare Products Regulatory Agency announces Aug. 11. Under the new guidelines, aspirin may be promoted for secondary prevention of heart attacks, while calcium and vitamin D products may be touted to prevent osteoporosis. Agency proposed amending the 1994 regulations in a November 2002 consultation letter (1"The Tan Sheet" Nov. 11, 2002, p. 17). Forty-one comments were received, of which 13 opposed removal of the restrictions and 31 supported the initiative...

UK on OTC ads

Guidelines for advertisements promoting OTCs for previously restricted indications are expected by year-end, UK's Medicines & Healthcare Products Regulatory Agency announces Aug. 11. Under the new guidelines, aspirin may be promoted for secondary prevention of heart attacks, while calcium and vitamin D products may be touted to prevent osteoporosis. Agency proposed amending the 1994 regulations in a November 2002 consultation letter (1"The Tan Sheet" Nov. 11, 2002, p. 17). Forty-one comments were received, of which 13 opposed removal of the restrictions and 31 supported the initiative...

UK on OTC ads

Guidelines for advertisements promoting OTCs for previously restricted indications are expected by year-end, UK's Medicines & Healthcare Products Regulatory Agency announces Aug. 11. Under the new guidelines, aspirin may be promoted for secondary prevention of heart attacks, while calcium and vitamin D products may be touted to prevent osteoporosis. Agency proposed amending the 1994 regulations in a November 2002 consultation letter (1"The Tan Sheet" Nov. 11, 2002, p. 17). Forty-one comments were received, of which 13 opposed removal of the restrictions and 31 supported the initiative...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094747

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel